Sfoglia per AUTORE
GRASSO M
Collezione AO Cuneo

  

Items : 23

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. in The Lancet. Oncology / Lancet Oncol. 2023 Oct;24(10):1119-1133. doi: 10.1016/S1470-2045(23)00405-9. Epub 2023 Sep 14.

2023
AO Cuneo
AOU Città della Salute di Torino

Musto P; Boccadoro M; Gay F; Sonneveld P; Vangsted AJ; Benjamin R; Hájek R; Silkjaer T; Caers J; Zweegman S; Mancuso K; Razawy W; Tacchetti P; Offidani M; Grasso M; Giaccone L; van der Velden VHJ; Pour L; Lund T; Gadisseur A; Pietrantuono G; Roeloffzen WWH; Broijl A; Schjesvold F; Wu KL; van der Holt B; Minnema MC; van de Donk NWCJ;

Stroke with large vessel occlusion in the posterior circulation: IV thrombolysis plus thrombectomy versus IV thrombolysis alone. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2023 Oct;56(3):454-462. doi: 10.1007/s11239-023-02844-4. Epub 2023 Jun 28.

2023
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Toni D; Mangiafico S; Caproni S; Russo M; Allegritti M; Amistà P; Puglielli E; Casalena A; Pedicelli A; Frisullo G; Invernizzi P; Pavia M; Petruzzelli M; Franchini E; Bruni S; Silvestrini M; Chiumarulo L; Comai A; Fasano A; Lozupone E; Sepe F; Grasso MF; Romano G; Gallesio I; Motto C; Sacco S; Giorgianni A; Piano M; Cariddi LP; et alii...

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun.

2023
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Tacchetti P; Zucchetta P; Pascarella A; Villanova T; De Cicco G; Patriarca F; Fioritoni F; Priola C; Sgherza N; Grasso M; Versari A; Bertamini L; Gamberi B; Albano D; Zambello R; Racca M; Galli M; Belotti A; D'Agostino M; Rota-Scalabrini D; Capra A; Gay F; Oliva S; Zamagni E; Mancuso K; Barbato S; Boccadoro M; Musto P; et alii...

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial. in The Lancet. Oncology / Lancet Oncol. 2023 Jan;24(1):64-76. doi: 10.1016/S1470-2045(22)00693-3. Epub 2022 Dec 14.

2023
AOU Città della Salute di Torino
AO Cuneo

Boccadoro M; Gay F; Ballanti S; Belotti A; Giuliani N; De Rosa L; Gozzetti A; Cellini C; Bertamini L; Grasso M; Zamagni E; Fioritoni F; Cea M; Pescosta N; Vincelli ID; Ronconi S; Pavone V; Capra A; Oddolo D; de Fabritiis P; Palmas A; Mina R; Paris L; Aquino S; Gamberi B; Rota-Scalabrini D; Musto P;

IV thrombolysis plus thrombectomy versus IV thrombolysis alone for minor stroke with anterior circulation large vessel occlusion from the IRETAS and Italian SITS-ISTR cohorts. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2023 Dec;44(12):4401-4410. doi: 10.1007/s10072-023-06948-w. Epub 2023 Jul 17.

2023
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara
AOU Alessandria

On Behalf Of The Iretas Group; Toni D; Mangiafico S; Mannino M; Galvano G; Sicurella L; Franchini E; Comai A; Pauciulo A; Rizzo A; Grasso MF; Romano G; Motto C; Gallesio I; Sepe FN; Piano M; Cariddi LP; Orlandi B; Giorgianni A; Filauri P; Tarletti R; Guzzardi G; Baracchini C; Causin F; Critelli A; Scoditti U; Cavasin N; Menozzi R; Melis M; et alii...

Immune dysfunctions affecting bone marrow V?9V?2 T cells in multiple myeloma: Role of immune checkpoints and disease status. in Frontiers in immunology / Front Immunol. 2022 Dec 20;13:1073227. doi: 10.3389/fimmu.2022.1073227. eCollection 2022.

2022
AOU Città della Salute di Torino
AO Cuneo

Avonto I; Massaia M; Riganti C; Grasso M; Kopecka J; D'Agostino M; Larocca A; Tripoli E; Grimaldi D; Castella B; Giannotta C;

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases. in Clinical case reports / Clin Case Rep. 2021 Jan 13;9(3):1066-1071. doi: 10.1002/ccr3.3593. eCollection 2021 Mar.

2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino

Rapezzi D; Zonta A; Priotto R; Masturzo B; Foglietta M; Mordini N; Mattei D; Celeghini I; Grosso E; Giacchello R; Signorile AF; Castellino C; Bonferroni M; Grasso M; Sorasio R; Castellino A; Elba S; Massaia M;

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Bonello F; Monaco F; Corradini P; Boccadoro M; Offidani M; Mina R; Ballanti S; De Sabbata G; Aquino S; De Paoli L; Grasso M; Cellini C; Paris L; Belotti A; Tacchetti P; Cea M; Zambello R; Musolino C; Patriarca F; Rota-Scalabrini D; Capra A; Pescosta N; Petrucci MT; Ciccone G; Bringhen S; Liberati AM; Falcone AP; Larocca A;

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1705-1720. doi: 10.1016/S1470-2045(21)00535-0. Epub 2021 Nov 11.

2021
AO Cuneo
AOU Città della Salute di Torino

Boccadoro M; Cavo M; Corradini P; Petrucci MT; Zambello R; Gamberi B; Aquino S; Palmas A; de Fabritiis P; Giuliani N; D'Agostino M; Capra A; Patriarca F; Cea M; Spadano A; Grasso M; Ballanti S; Zamagni E; Ledda A; Offidani M; Galli M; Belotti A; Bertamini L; Rota-Scalabrini D; Musto P; Gay F;

Validation of an Algorithm to Detect Multiple Sclerosis Cases in Administrative Health Databases in Piedmont (Italy): An Application to the Estimate of Prevalence by Age and Urbanization Level. in Neuroepidemiology / Neuroepidemiology. 2021;55(2):119-125. doi: 10.1159/000513763. Epub 2021 Mar 10.

2021
AO Cuneo
ASL Torino 3
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Golini N; Leone MA; Cantello R; Barizzone N; Bertolotto A; Richiardi P; Grasso MF; Cavalla P; Alboini PE; Gnavi R; Picariello R; D'Alfonso S;

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.

2020
ASL Biella
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Alessandria

Sonneveld P; Boccadoro M; Larocca A; Musto P; Romano A; Ria R; Giuliani N; Offidani M; Liberati AM; Marchetti M; Mosca-Siez ML; de Fabritiis P; Ballanti S; Monaco F; Gobbi M; Cellini C; Grasso M; Ronconi S; Pescosta N; Petrucci MT; Capra A; Zambello R; Mina R; Di Lullo G; Belotti A;

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. in Journal of medical case reports / J Med Case Rep. 2020 Jun 22;14(1):75. doi: 10.1186/s13256-020-02380-2.

2020
AO Cuneo

Massaia M; Fraternali Orcioni G; Giordano F; Grasso M; Celeghini I; Rapezzi D; Foglietta M; Mordini N; Drandi D; Strola G; Mattei D; Bonferroni M; Castellino C; Soriasio R; Castellino A; Elba S;

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. in The Lancet. Haematology / Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.

2020
AOU Città della Salute di Torino
AO Cuneo

Sonneveld P; Boccadoro M; Carvalho S; Spencer A; Palmas A; Cafro AM; Minnema M; Mandigers C; van Marwijk Kooy M; Gimsing P; Mellqvist UH; Waage A; Driessen C; Specchia G; Zander T; Caravita di Toritto T; Durian M; von dem Borne PA; Hajek R; Wu KL; Boersma R; Morelli AM; Aquino S; Ludwig H; Levin MD; Bos G; Pascarella A; Benevolo G; Troia R; et alii...

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.

2020
ASL Torino 4
AOU Città della Salute di Torino
AO Cuneo

Boccadoro M; Larocca A; Hájek R; Falco P; Palumbo A; Cellini C; Marasca R; Gentile M; Baldini L; Tosi P; Petrucci MT; Santoro A; Poggiu M; Aquino S; Gazzera G; De Rosa L; Pavone V; Pescosta N; Pezzatti S; Grasso M; Rota-Scalabrini D; Spada S; Paris L; Ballanti S; Bringhen S; D'Agostino M;

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 29;14(1):20. doi: 10.3390/ph14010020.

2020
AO Cuneo
AOU Città della Salute di Torino

Celeghini I; Castellino A; Boccadoro M; Bringhen S; Bonello F; Grasso M; D'Agostino M;

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial. in Journal of hematology & oncology / J Hematol Oncol. 2019 Jan 9;12(1):4. doi: 10.1186/s13045-018-0691-4.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Ria R; Vacca A; Dammacco F; Boccadoro M; Petrucci MT; Musto P; Montefusco V; Rizzo M; Gottardi D; Falcone AP; Grasso M; Leonardi G; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Patriarca F; Martino E; Larocca A; Offidani M; De Paoli L; Bringhen S; Palumbo A; Omedè P; Terragna C; Giuliani N; Morabito F; Saltarella I; et alii...

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at non invasive prenatal screening test (NIPT): Report of two cases in Haematologica

2019
AO Cuneo

Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Grasso M; Mattei D; Mordini N; Foglietta M; Mastruzo B; Priotto R; Zonta A; Rapezzi D; Massaia M;

IgM multiple myeloma and waldenstrom macroglobulinemia: Diagnostic challenges and therapeutic options. A report of two cases in Haematologica

2019
AO Cuneo

Elba S; Castellino A; Bonferroni M; Castellino C; Mattei D; Mordini N; Foglietta M; Priotto R; Rapezzi D; Sorasio R; Grasso M; Massaia M;

Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy. in Haematologica / Haematologica. 2018 Oct;103(10):e469-e472. doi: 10.3324/haematol.2017.182865. Epub 2018 Apr 26.

2018
AO Cuneo

Nagler A; Sanderson RD; Rambaldi A; Pace S; Paoletti D; Barbieri P; Celeghini I; Einsele H; Magen H; Specchia G; Grasso M; Galli M; Chatterjee M;

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2018 Jul;24(7):1372-1378. doi: 10.1016/j.bbmt.2018.01.035. Epub 2018 F

2018
AO Cuneo

Ladetto M; Einsele H; Caillot D; Grasso M; Pohlreich D; Schäfer-Eckart K; Lenain P; Metzner B; Radocha J; Peschel C; Koenecke C; Blaise D; Potter M; Leleu X; Krejci M; Bourhis JH; Johansson JE; Goldschmidt H; Schönland S; Kröger N; Koster L; Iacobelli S; Garderet L;

Lack of prognostic value for peripheral absolute monocyte count in a population of diffuse large b-cell lymphoma in the rituximab era in Hematological Oncology

2015
AO Cuneo
AOU Città della Salute di Torino

Aprile Von Hohenstaufen K; Gulden-Sala W; Margiotta-Casaluci G; Franceschetti S; Moccia AA; Bertoni F; Cavalli F; Stathis A; Ghielmini M; Stussi G; Zucca E; Gaidano G; Conconi A; Canepari M; Gonella A; Castellino C; Sorasio R; Bonferroni M; Mattei D; Mordini N; Borra A; Rapezzi D; Margaria F; Conte E; Celeghini I; Bertolotti L; Fiore F; Grasso M; Ciammella P; et alii...

Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2014 May;20(5):717-23. doi: 10.1016/j.bbmt.2014.02.002. Epub 2014 Feb

2014
AO Cuneo

Gallamini A; Ghiglia A; Borra A; Celeghini I; Fiore F; Mordini N; Mattei D; Castellino C; Di Marco C; Marenchino D; Rapezzi D; Strola G; Grasso M; Bonferroni M; Sorasio R;

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.

2014
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Montefusco V; Zambello R; Gottardi D; Franceschini L; Grasso M; Vincelli ID; Benevolo G; Levi A; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Palumbo A; Falcone AP; Omedé P; Marasca R; Morabito F; Mina R; Guglielmelli T; Nozzoli C; Passera R; Gaidano G; Offidani M; Ria R; Petrucci MT; Musto P; Boccadoro M; et alii...